-
Randomized Controlled Trial Multicenter Study
PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial.
- Pluto Collaborative Study Group, Mark Kilby, Khalid Khan, Katie Morris, Jane Daniels, Richard Gray, Laura Magill, Bill Martin, Peter Thompson, Zarko Alfirevic, Simon Kenny, Sarah Bower, Stephen Sturgiss, Dilly Anumba, Gerald Mason, Graham Tydeman, Peter Soothill, Karen Brackley, Pamela Loughna, Alan Cameron, Sailesh Kumar, and Phil Bullen.
- BJOG. 2007 Jul 1;114(7):904-5, e1-4.
ObjectivesThe primary objective is to determine whether intrauterine vesicoamniotic shunting for fetal bladder outflow obstruction, compared with conservative, noninterventional care, improves prenatal and perinatal mortality and renal function. The secondary objectives are to determine if shunting for fetal bladder outflow obstruction improves perinatal morbidity, to determine if improvement in outcomes is related to prognostic assessment at diagnosis and, if possible, derive a prognostic risk index and to determine the safety and long-term efficacy of shunting.DesignA multicentre randomised controlled trial (RCT).SettingFetal medicine units.PopulationPregnant women with singleton, male fetus with isolated lower urinary tract obstruction (LUTO).MethodsFollowing ultrasound diagnosis of LUTO in a male fetus and exclusion of other structural and chromosomal anomalies, participation in the trial will be discussed with the mother and written information given. Consent for participation in the trial will be taken and the mother randomised via the internet to either insertion of a vesicoamniotic shunt or expectant management. During pregnancy, both groups will be followed with regular ultrasound scans looking at viability, renal measurements and amniotic fluid volume. Following delivery, babies will be followed up by paediatric nephrologists/urologists at 4-6 weeks, 12 months and 3 and 5 years to assess renal function via serum creatinine, renal ultrasound and need for dialysis/transplant.Main Outcome MeasuresThe main outcome measures will be perinatal mortality rates and renal function at 4-6 weeks and 12 months measured via serum creatinine, renal ultrasound and need for dialysis/transplant.FundingWellbeing of Women. ESTIMATED COMPLETION DATE: September 2010. TRIAL ALGORITHM: [flowchart: see text].
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.